Hearing Loss Trial, Recruiting NCT02630589 Sponsor: University Medical Center Groningen Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT02630589
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have tinnitus (ringing or noise in the ears) in one ear only
  • People whose tinnitus severely impacts their daily life
  • Men or women aged 18 years or older
  • People whose tinnitus has been present for more than 1 year and has stayed the same during that time
  • People whose tinnitus has not improved after trying standard treatments, such as hearing aids and cognitive behavioural therapy (CBT), for a reasonable length of time
  • People whose affected ear has a moderate-to-severe hearing loss, within a specific measured range (confirm with trial site)
  • People whose other ear has functional hearing that is significantly better than the affected ear, within a specific measured range (confirm with trial site)
  • People who have given informed consent after receiving detailed written and verbal information about the surgery, possible complications, and the uncertain effect of the implant on tinnitus

Who may not be able to join:

  • People whose tinnitus has an identifiable cause that requires its own treatment, such as certain tumours, ear bone abnormalities, or blood vessel conditions — as determined by imaging and ear specialist examinations
  • People with a diagnosed psychiatric condition or an unstable mental health situation, as assessed by a psychiatrist
  • People who, in the opinion of the investigator and/or psychiatrist, have unrealistic expectations about the treatment
  • People with a life expectancy of less than 5 years
  • People with a history of blood clotting problems
  • People whose general health risk is above a certain level as rated by a standard medical scale (confirm with trial site)
  • People who are pregnant
  • People whose skull structure would prevent the implant device from being placed correctly
  • People whose anatomy or surgical circumstances would prevent the electrode part of the implant from being placed correctly
  • People with a known allergy or intolerance to the materials used in the implant, including medical-grade silicone, platinum, iridium, or parylene C

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 July 2016
Est. completion
1 January 2028

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Tinnitus Functioning Index (TFI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov